Skip to main content
Clinical Trials/NCT04774978
NCT04774978
Unknown
Not Applicable

Real-time Automatic Continuous Cardiac Output Measurements Using Transthoracic Echocardiography (TTE) in ICU-patients in Comparison to Flotrac Measurements

Rijnstate Hospital0 sites20 target enrollmentMarch 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Output, Low
Sponsor
Rijnstate Hospital
Enrollment
20
Primary Endpoint
Patients in which the ProbeFix can be used continuously
Last Updated
5 years ago

Overview

Brief Summary

Study to assess the feasibility of real-time automatic cardiac output measurements using transthoracic echocardiography (TTE)

Detailed Description

Rationale: Study to assess the feasibility of real-time automatic cardiac output measurements using transthoracic echocardiography (TTE) Objective: To assess the correlation and feasibility of real-time automatic continuous cardiac output measurements using transthoracic ultrasound (TTE) in adult ICU-patients in comparison to Flotrac measurements Study design: prospective, feasibility study Study population: Adult Intensive Care patients ( \> 18 years) Intervention (if applicable): Consecutive adult patients on the ICU in which the there is an indication for continuous cardiac output measurements. Main study parameters/endpoints: * Percentage of patients in which continuous cardiac output can be measured using TTE * Correlation between continuous TTE and Flotrac measurements

Registry
clinicaltrials.gov
Start Date
March 1, 2021
End Date
July 1, 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Rijnstate Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult Intensive Care patients ( \> 18 years)

Exclusion Criteria

  • Pregnancy
  • Atrial fibrillation or other irregular heart rhythm

Outcomes

Primary Outcomes

Patients in which the ProbeFix can be used continuously

Time Frame: 2 months

Percentages will be reported

Secondary Outcomes

  • Correlation between continuous TTE and Flotrac(2 months)

Similar Trials